Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic - 25/01/22
Doi : 10.1016/j.rmed.2020.106120
Thomas M. Berghaus ⁎, 1 
Department of Cardiology, Respiratory Medicine and Intensive Care, University Hospital Augsburg, Augsburg University, Germany
Ludwig-Maximilians-University Munich, Germany
∗Corresponding author.University Hospital, Stenglinstrasse 2, D-86156, Augsburg, Germany.University HospitalStenglinstrasse 2AugsburgD-86156Germany
Sabine Haberl
Department of Cardiology, Respiratory Medicine and Intensive Care, University Hospital Augsburg, Augsburg University, Germany
Martin Schwaiblmair
Department of Cardiology, Respiratory Medicine and Intensive Care, University Hospital Augsburg, Augsburg University, Germany
Ludwig-Maximilians-University Munich, Germany
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Keywords : Hospital admissions, Exacerbated COPD, COVID-19 pandemic
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2020
Elsevier Ltd. Tutti i diritti riservati.
Vol 191
Articolo 106120- gennaio 2022 Ritorno al numero
Articolo precedente
- Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
- Eric D. Bateman, Asif H. Khan, Yingxin Xu, Patricia Guyot, Jingdong Chao, Siddhesh Kamat, Paul Rowe, Heather Burnett, Jerome Msihid, David M. Weinreich, Ian D. Pavord
- Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
- Katsunori Kagohashi, Kunihiko Miyazaki, Hiroaki Satoh
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.